on 01 Oct 2020
Last Applicant/ Owned by
Avonbridge House
GB
Serial Number
79088558 filed on 30th Sep 2010
Registration Number
4054581 registered on 15th Nov 2011
Correspondent Address
Mewburn Ellis LLP
Filing Basis
No Filing Basis
Disclaimer
"GENERICS"
The mark consists of a square device and the words "ALLIANCE GENERICS". The top half of the square device is in blue and the bottom half of the square device is in green. The words "ALLIANCE GENERICS" in the mark are in black. Pharmaceutical preparations and substances for the treatment of infectious diseases and disorders, cardiovascular diseases and disorders, central nervous system diseases an Read More
Pharmaceutical preparations and substances for the treatment of infectious diseases and disorders, cardiovascular diseases and disorders, central nervous system diseases and disorders, dental diseases and disorders, dermatological diseases and disorders, nutritional diseases and disorders, gynaecological diseases and disorders, rheumatological diseases and disorders, toxicological diseases and disorders, oncological diseases and disorders and endocrinological diseases and disorders
No 79088558
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
26.09.21 -
Squares that are completely or partially shaded
The mark consists of a square device and the words "ALLIANCE GENERICS". The top half of the square device is in blue and the bottom half of the square device is in green. The words "ALLIANCE GENERICS" in the mark are in black.
Status Date | Action Taken |
---|---|
17th Apr 2021 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
17th Apr 2021 | DEATH OF INTERNATIONAL REGISTRATION |
22nd Mar 2019 | TOTAL INVALIDATION PROCESSED BY THE IB |
28th Feb 2019 | INVALIDATION PROCESSED |
28th Feb 2019 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
22nd Feb 2019 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
22nd Jun 2018 | CANCELLED SECTION 71 |
10th Sep 2015 | NEW REPRESENTATIVE AT IB RECEIVED |
06th Jul 2012 | FINAL DECISION TRANSACTION PROCESSED BY IB |
20th Jun 2012 | FINAL DISPOSITION NOTICE SENT TO IB |